Metabolism and Physiological functions of endogenous D-serine
内源性D-丝氨酸的代谢和生理功能
基本信息
- 批准号:07557242
- 负责人:
- 金额:$ 3.01万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To obtain an insight into physiological and pathophysiological role of endogenous D-serine in higher brain functions, we have investigated the metabolism of D-serine in the rat and human brain tissues. Substantial concentration of D-serine has been detected in the extracellular fluid of the frontal cortex and striatum of the rat by an in vivo microdialysis technique. Neither calcium ion-free condition nor perfusion of tetrodotoxin reduced extracellular D-serine content in the frontal cortex and a depolarization agent, veratrin, caused an increase in the extracellular release of glutamate, but not D-serine. These data suggest that extracellular D-serine could be liberated from glial cells. [3H]D-Serine was found to be taken up into the cortical and cerebellar P2 franction and the C6 glioma cells in a temperature-and sodium-dependent and saturable manner, indicating the presence a transport system for D-serine. In addition to the glycine modulatory site of the NMDA receptor at which D-serine acts as a potent agonist, [3H]D-serine has also been shown to bind to a novel site in the brain tissues. Moreover, we have observed a profound reduction of cortical D-serine contents in the patients with non-ketotic hyperglycinemia lacking activity of glycine cleavage system (GCS) and in the animal treated with an inhibitor of GCS,cysteamine. Systemic administration of a high amount of L-serine produced a marked increase in cortical D-serine concentrations in the infant rats, vice versa. The present findings further support the view that endogenous D-serine may be involved in the synaptic transmission mediated by the NMDA receptor and other unknown receptor sites. The synthesis of D-serine might be closely related to the metabolism of L-serine and glycine.
为了了解内源性D-丝氨酸在较高脑功能中的生理和病理生理学作用,我们研究了大鼠和人脑组织中D-丝氨酸的代谢。通过体内微透析技术,已经在额叶皮层和大鼠纹状体的细胞外流体和大鼠纹状体的细胞外流体中检测到了大量的D-丝氨酸。额叶皮质中的细胞外D-丝氨酸含量和去极化剂Veratrin均未导致细胞外释放的谷氨酸盐释放增加,但没有D-丝氨酸的增加。这些数据表明,细胞外D-丝氨酸可以从神经胶质细胞中释放出来。 [3H]发现D-塞林以温度依赖性且可饱和的方式被带入皮质和小脑P2骨骼和C6胶质瘤细胞中,表明存在D-丝氨酸的传输系统。除了NMDA受体的甘氨酸调节位点,在该甘氨酸受体中,D丝氨酸充当有效的激动剂,[3H] D丝氨酸也已被证明与脑组织中的新位点结合。此外,我们已经观察到缺乏甘氨酸裂解系统(GCS)活性的非菠萝高血糖患者以及用GCS抑制剂CySteamine治疗的动物中,皮质D-丝氨酸含量的大幅降低。全身给药大量的L-塞琳在婴儿大鼠的皮质D-丝氨酸浓度显着增加,反之亦然。目前的发现进一步支持了以下观点:内源性D-丝氨酸可能参与由NMDA受体和其他未知受体部位介导的突触传播。 D丝氨酸的合成可能与L塞林和甘氨酸的代谢密切相关。
项目成果
期刊论文数量(68)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matsui T,Sekiguchi M,Hashimoto A,Tomita U,Nishikawa T and Wada K: "Functional comparison of D-serine and glycine in rodents : The effects on cloned NMDA receptors and the extracellular concentration" J Neurochem. 65. 454-458 (1995)
Matsui T、Sekiguchi M、Hashimoto A、Tomita U、Nishikawa T 和 Wada K:“D-丝氨酸和甘氨酸在啮齿动物中的功能比较:对克隆 NMDA 受体和细胞外浓度的影响”J Neurochem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
西川 徹: "KEY WORD 1997-‘98 精神(「興奮性アミノ酸と精神分裂症」)" 先端医学社, 268(2) (1997)
Toru Nishikawa:“关键词 1997-98 精神病学(“兴奋性氨基酸和精神分裂症”)”仙台医学社,268(2)(1997)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matoba M,Tomita U and Nishikawa T: "Characterization of 5,7-dichlorlokynurenate-insensitive [3H]D-serine binding to synaptosomal fraction isolated from rat brain tissues." J Neurochem. 69. 399-405 (1997)
Matoba M、Tomita U 和 Nishikawa T:“5,7-二氯炔尿酸不敏感的 [3H]D-丝氨酸与从大鼠脑组织中分离的突触体部分结合的表征。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tanaka K,Watase K,Manabe T,Yamada K,Watanabe M,Yamada K,Watanabe M,Takahashi K,Iwama H,Nishikawa T,Ichihara N,Kikuchi K,Okuyama S,Kawashima N,Hori and Wada K.: "Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1." Sc
田中 K、渡濑 K、真锅 T、山田 K、渡边 M、山田 K、渡边 M、高桥 K、岩间 H、西川 T、市原 N、菊池 K、奥山 S、川岛 N、堀和和田 K.:“癫痫症
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
西川 撤: "精神疾患とシナプス,特集:シナプスと疾患" Clinical Neuroscinece. 14. 105-108 (1996)
Rei Nishikawa:“精神疾病和突触,专题:突触和疾病”《临床神经科学》14. 105-108 (1996)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NISHIKAWA Toru其他文献
NISHIKAWA Toru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NISHIKAWA Toru', 18)}}的其他基金
Studies on the development of novel pharmacotherapy for schizophrenia that regulates the glutamate receptors
调节谷氨酸受体的精神分裂症新型药物疗法的开发研究
- 批准号:
21390330 - 财政年份:2009
- 资助金额:
$ 3.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on the development of glutamate system-targeted novel pharmacotherapy for schizophrenia
谷氨酸系统靶向治疗精神分裂症新药开发研究
- 批准号:
19390302 - 财政年份:2007
- 资助金额:
$ 3.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of molecular pathomechanisms of schizophrenia
阐明精神分裂症的分子病理机制
- 批准号:
17025016 - 财政年份:2005
- 资助金额:
$ 3.01万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
A neurodevelopmental pharmacological approach to the molecular pathophysiology of schizophrenic symptoms
精神分裂症症状分子病理生理学的神经发育药理学方法
- 批准号:
14207040 - 财政年份:2002
- 资助金额:
$ 3.01万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A pharmacological approach to the molecular basis of disturbed brain information processing of schizophrenia
精神分裂症大脑信息处理紊乱的分子基础的药理学方法
- 批准号:
12470192 - 财政年份:2000
- 资助金额:
$ 3.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
精神分裂病における神経情報処理障害の原因となる遺伝子異常の探索
寻找导致精神分裂症神经信息处理障碍的遗传异常
- 批准号:
10670929 - 财政年份:1998
- 资助金额:
$ 3.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of schizophrenic symptoms
精神分裂症症状的分子机制
- 批准号:
08671124 - 财政年份:1996
- 资助金额:
$ 3.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular pharmacological approach to the disturbances of brain neuron circuits involved in schizophrenia
精神分裂症脑神经元回路紊乱的分子药理学方法
- 批准号:
06670993 - 财政年份:1994
- 资助金额:
$ 3.01万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Schizophrenic sympyoms-related disturbance of cerebral neurotransmission
精神分裂症症状相关的脑神经传递障碍
- 批准号:
04670718 - 财政年份:1992
- 资助金额:
$ 3.01万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Behavioral and biochemical effects of schizophrenomimetic drugs, phencyclidine and methamphetamine, in the rat
精神分裂拟态药物苯环己哌啶和甲基苯丙胺对大鼠的行为和生化影响
- 批准号:
02670527 - 财政年份:1990
- 资助金额:
$ 3.01万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
无义介导的mRNA降解通路分子Smg6在哺乳动物大脑发育中的功能及其机制研究
- 批准号:31770871
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
哺乳动物大脑皮层病理痛信息编码与加工的神经回路及可塑性
- 批准号:81070899
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
In situ Single-Cell Multi-Omic and Morphological Profiling in Mammalian Brains
哺乳动物大脑的原位单细胞多组学和形态学分析
- 批准号:
10506297 - 财政年份:2022
- 资助金额:
$ 3.01万 - 项目类别:
Mammalian vocal communication as a model for human language; from genes and brains to behaviour
哺乳动物的声音交流作为人类语言的模型;
- 批准号:
MR/T021985/1 - 财政年份:2020
- 资助金额:
$ 3.01万 - 项目类别:
Fellowship
New Approaches for Investigating Brain-Body Scaling and the Evolution of Mammalian Brains
研究哺乳动物大脑脑体尺度和进化的新方法
- 批准号:
0518819 - 财政年份:2005
- 资助金额:
$ 3.01万 - 项目类别:
Standard Grant
Molecular mechanisms of schizophrenic symptoms
精神分裂症症状的分子机制
- 批准号:
08671124 - 财政年份:1996
- 资助金额:
$ 3.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Imaging the Diversity of Mammalian Brains: An Electronic Catalog for Wide Accessibility
哺乳动物大脑多样性成像:可广泛使用的电子目录
- 批准号:
9111592 - 财政年份:1991
- 资助金额:
$ 3.01万 - 项目类别:
Standard Grant